The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases
Authors:
- 1 November 2017
- journal article
- research article
- Published by Elsevier in Respiratory Investigation
- Vol. 55 (6) , 380-383
Abstract
No abstract availableKeywords
Funding Information
- Infection Control Oita Network (ICON)
This publication has 9 references indexed in Scilit:
- Additional treatment with clarithromycin reduces fever duration in patients with influenzaRespiratory Investigation, 2014
- Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective AnalysisPLOS ONE, 2013
- Oral Clarithromycin Enhances Airway Immunoglobulin A (IgA) Immunity through Induction of IgA Class Switching Recombination and B-Cell-Activating Factor of the Tumor Necrosis Factor Family Molecule on Mucosal Dendritic Cells in Mice Infected with Influenza A VirusJournal of Virology, 2012
- Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infectionJournal of Infection, 2012
- Clarithromycin Inhibits Type A Seasonal Influenza Virus Infection in Human Airway Epithelial CellsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenzaRespirology, 2009
- Clarithromycin Inhibits Progeny Virus Production from Human Influenza Virus-Infected Host CellsBiological and Pharmaceutical Bulletin, 2008
- Therapeutic Effect of Erythromycin on Influenza Virus-induced Lung Injury in MiceAmerican Journal of Respiratory and Critical Care Medicine, 1998
- A Mechanism of Erythromycin Treatment in Patients with Diffuse PanbronchiolitisAmerican Review of Respiratory Disease, 1993